Caprock Group LLC Buys New Stake in Kenvue Inc. $KVUE

Caprock Group LLC bought a new position in Kenvue Inc. (NYSE:KVUE) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 63,662 shares of the company’s stock, valued at approximately $1,033,000.

A number of other institutional investors have also made changes to their positions in the business. CWM LLC increased its holdings in Kenvue by 6.6% in the 2nd quarter. CWM LLC now owns 31,265 shares of the company’s stock valued at $654,000 after buying an additional 1,923 shares during the period. Sequoia Financial Advisors LLC increased its position in Kenvue by 4.9% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 27,226 shares of the company’s stock valued at $570,000 after buying an additional 1,273 shares in the last quarter. Allianz Asset Management GmbH increased its position in shares of Kenvue by 57.6% during the second quarter. Allianz Asset Management GmbH now owns 45,368 shares of the company’s stock worth $950,000 after acquiring an additional 16,580 shares in the last quarter. Private Trust Co. NA boosted its holdings in Kenvue by 75.6% during the second quarter. Private Trust Co. NA now owns 11,977 shares of the company’s stock worth $251,000 after purchasing an additional 5,158 shares during the last quarter. Finally, Chevy Chase Trust Holdings LLC grew its stake in Kenvue by 0.8% in the 2nd quarter. Chevy Chase Trust Holdings LLC now owns 1,015,087 shares of the company’s stock valued at $21,246,000 after purchasing an additional 7,990 shares during the period. Institutional investors own 97.64% of the company’s stock.

Insider Buying and Selling

In other news, Director Jeffrey C. Smith bought 3,200,000 shares of the stock in a transaction that occurred on Friday, December 12th. The stock was bought at an average cost of $17.37 per share, for a total transaction of $55,584,000.00. Following the acquisition, the director directly owned 27,307,632 shares of the company’s stock, valued at $474,333,567.84. The trade was a 13.27% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 0.17% of the company’s stock.

Analyst Ratings Changes

KVUE has been the topic of several analyst reports. Canaccord Genuity Group reiterated a “hold” rating and set a $15.00 price target (down from $26.00) on shares of Kenvue in a research report on Wednesday, October 29th. Weiss Ratings reissued a “hold (c-)” rating on shares of Kenvue in a research note on Friday, January 9th. Edward Jones lowered shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 3rd. Barclays lifted their price target on Kenvue from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Monday, November 10th. Finally, Jefferies Financial Group downgraded Kenvue from a “buy” rating to a “hold” rating and dropped their target price for the stock from $23.00 to $18.00 in a research report on Friday, January 30th. Four investment analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $19.46.

Kenvue Price Performance

Kenvue stock opened at $18.70 on Monday. The company has a quick ratio of 0.69, a current ratio of 0.98 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $25.17. The company has a market cap of $35.82 billion, a price-to-earnings ratio of 24.93 and a beta of 0.59. The firm’s fifty day moving average is $17.38 and its 200 day moving average is $17.70.

Kenvue Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th will be given a dividend of $0.2075 per share. The ex-dividend date is Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a yield of 4.4%. Kenvue’s dividend payout ratio is currently 110.67%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.